Table 2.
Performance comparison among PD-L1 antibodies using Fleiss’ kappa analyses to compare performance and intraclass correlation coefficient (ICC) to compare tumor cell (TC) and immune cell (IC) percentages.
Kappa analyses for antibody performance | |||
---|---|---|---|
Kappa | 95% confidence interval | P Value | |
SP142 vs. 22C3 | 0.791 | 0.660–0.922 | <0.001 |
SP243 vs. E1L3N | 0.762 | 0.631–0.893 | <0.001 |
22C3 vs. E1L3N | 0.743 | 0.612–0.873 | <0.001 |
SP263 vs. SP142 | 0.724 | 0.593–0.855 | <0.001 |
SP263 vs. 22C3 | 0.706 | 0.575–0.837 | <0.001 |
SP142 vs. E1L3N | 0.639 | 0.508–0.770 | <0.001 |
ICC analyses for TC percentage | |||
ICC | 95% confidence interval | P value | |
All four clones | 0.900 | 0.870–0.923 | <0.001 |
SP263 vs. E1L3N | 0.949 | 0.933–0.961 | <0.001 |
22C3 vs. E1L3N | 0.939 | 0.918–0.955 | <0.001 |
SP263 vs. 22C3 | 0.929 | 0.905–0.947 | <0.001 |
SP142 vs. 22C3 | 0.619 | 0.481–0.717 | <0.001 |
SP263 vs. SP142 | 0.525 | 0.340–0.652 | <0.001 |
SP142 vs E1L3N | 0.500 | 0.320–0.629 | <0.001 |
ICC analyses for IC percentage | |||
ICC | 95% confidence interval | P value | |
All four clones | 0.805 | 0.76–0.844 | <0.001 |
22C3 vs. E1L3N | 0.866 | 0.826–0.897 | <0.001 |
SP263 vs. SP142 | 0.722 | 0.638–0.786 | <0.001 |
SP263 vs. E1L3N | 0.695 | 0.595–0.769 | <0.001 |
SP142 vs. E1L3N | 0.667 | 0.567–0.744 | <0.001 |
SP263 vs. 22C3 | 0.567 | 0.435–0.668 | <0.001 |
SP142 vs. 22C3 | 0.519 | 0.376–0.630 | <0.001 |